The University Clinical Center Tuzla, Clinic of Hematology and Radiotherapy will host a press briefing on 17 January, 2017, beginning at 11 a.m. to announce a purchase of ultrasound device for the treatment of hematology patients.
The press briefing will attend Ass. Prof. Nešad Hotić, director of the University Clinical Center Tuzla, Prof. Dr. Aida Arnautović- Ćustović, head of of the Department of Hematology, and Vedran Crnogorac, Novartis representative.
